Investor Diligence and Decision Support
We support VC/CVC teams, Private Equity, Hedge Funds, and other investors with decision-grade intelligence in BioPharma, HealthTech, and AI-enabled healthcare. From fast diligence to ongoing monitoring, we help you validate assumptions, surface risks early, and act with confidence.
From identifying emerging trends and hidden risks to supporting diligence and portfolio decisions, we deliver concise, actionable recommendations that create an edge.
Our work commonly includes:
- Landscape + diligence (science, commercial, competitive dynamics)
- Company/asset profile (TAM, segmentation, growth drivers, value proposition)
- Opportunity/risk assessment (red flags, catalysts, scenarios, mitigations)
- Custom research aligned to your thesis and timelines (deal-specific questions, thesis validation, monitoring)
Typical engagement modes:
- Diligence Sprint (5–10 business days)
- Monthly monitoring and brief updates
- Decision workshops and AI-powered wargaming when stakes are high
Don’t forget to check out our Lucid Diligence Briefs, delivering 60-second theses, questions to ask, red flags and catalysts to watch, linked to trending news.
Want to move faster on your next decision? Contact: info@lqventures.com
February 24, 2025
Oncology Weekly News – February 24th 2025
February 20, 2025
ESGO 2025 Preview: Highlights in Gynecologic Oncology to Watch
February 19, 2025
ECCO 2025 Preview: Key Crohn’s and Colitis Highlights to Watch
February 18, 2025
Obesity Weekly News – Feb 18th 2025
February 17, 2025
Hematology Weekly News – February 17th 2025
February 17, 2025
Oncology Weekly News – February 17th 2025
February 12, 2025
Obesity Weekly News – Feb 12th 2025
February 10, 2025
Oncology Weekly News – February 10th 2025
February 10, 2025
Hematology Weekly News – February 10th 2025
January 30, 2025